These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6810459)

  • 1. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
    Weir RJ
    Scott Med J; 1982 Jul; 27(3):212-5. PubMed ID: 6810459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure changes and hormonal contraceptives.
    Shen Q; Lin D; Jiang X; Li H; Zhang Z
    Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
    Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of combined oral contraceptive preparations.
    Singh BM; Nutter SA; Nattrass M
    Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure.
    Tsai CC; Williamson HO; Kirkland BH; Braun JO; Lam CF
    Am J Obstet Gynecol; 1985 Jan; 151(1):28-32. PubMed ID: 3966503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS; Mehta S; Virkar KD; Saxena BN
    Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indicators of arterial blood pressure during hormonal contraception].
    Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1985 Aug; (9):56-7. PubMed ID: 2416229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.